WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |

Search International and National Patent Collections
World Intellectual Property Organization
Machine translation
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/030200    International Application No.:    PCT/JP2004/014116
Publication Date: 07.04.2005 International Filing Date: 27.09.2004
A23L 1/30 (2006.01), A61K 31/353 (2006.01)
Applicants: KIRIN BEER KABUSHIKI KAISHA [JP/JP]; 10-1, Shinkawa 2-chome, Chuo-ku, Tokyo 1048288 (JP) (For All Designated States Except US).
KOBAYASHI, Mika [JP/JP]; (JP) (For US Only).
ODAI, Hideharu [JP/JP]; (JP) (For US Only).
FUJIWARA, Daisuke [JP/JP]; (JP) (For US Only).
SASAKI, Katsunori [JP/JP]; (JP) (For US Only)
Inventors: KOBAYASHI, Mika; (JP).
ODAI, Hideharu; (JP).
FUJIWARA, Daisuke; (JP).
SASAKI, Katsunori; (JP)
Agent: YOSHITAKE, Kenji; Kyowa Patent & Law Office, Room 323 Fuji Bldg., 2-3, Marunouchi 3-chome Chiyoda-ku Tokyo 1000005 (JP)
Priority Data:
2003-336014 26.09.2003 JP
2004-219071 27.07.2004 JP
(JA) 自己免疫疾患治療剤
Abstract: front page image
(EN)A remedy for diseases which can be effectively treated by inhibiting the production of Th1 cytokine and/or diseases which can be effectively treated by inhibiting the production of an autoantibody comprising, as the active ingredient, i) proanthocyanidine having a polymerization degree of at least 4, or ii) an extract of a plant material containing proanthocyanidine; an eradicative medicine for these diseases; and a medicine for inhibiting the progress of these diseases.
(FR)L'invention concerne un remède pour maladies auto-immunes pouvant être traitées efficacement par l'inhibition de la production de cytokine Th1 et/ou pour maladies pouvant être traitées efficacement par l'inhibition de la production d'auto-anticorps, comprenant, comme principe actif, I) de la proanthocyanidine à degré de polymérisation au moins égal à 4, ou ii) un extrait de matériau végétal qui renferme de la proanthocyanidine ; un médicament d'éradication correspondant aux maladies considérées ; et un médicament qui permet d'inhiber la progression de ces maladies.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)